No Result
View All Result
  • Login
Wednesday, October 8, 2025
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Markets

IPO News: MapLight Therapeutics targets 704 mln valuation in Nasdaq debut

by FeeOnlyNews.com
7 hours ago
in Markets
Reading Time: 2 mins read
A A
0
IPO News: MapLight Therapeutics targets 704 mln valuation in Nasdaq debut
Share on FacebookShare on TwitterShare on LInkedIn


In recent months, Wall Street has seen a surge of healthcare firms seeking to go public, as IPO activity continues to regain momentum after last year’s record lows.  MapLight Therapeutics, Inc. is the latest healthcare company to jump on the IPO bandwagon, eying a $704 million valuation.

The Offering

In a recent filing with the Securities and Exchange Commission, the company revealed its intention to offer 14.75 million shares in an initial public offering. Post-IPO, the stock is expected to trade on the Nasdaq stock exchange under the symbol MPLT. Morgan Stanley, Jefferies, Leerink Partners, and Stifel are the underwriters managing the offering.

The estimated IPO price is $17 per share, which translates into net proceeds of about $227.3 million after deducting offering expenses and other charges. The company plans to use the proceeds to advance the clinical development of its current programs, to fund research and development activities for additional programs, and for working capital and other general corporate purposes.

Loss Widens

MapLight has not yet generated revenue, since it doesn’t have any product in the market. In the six months ended June 30, 2025, the company incurred a loss of $52.2 million, compared to a loss $37.3 million in the corresponding period last year. Total operating expenses were $54.2 million in the first half.

MapLight is a clinical-stage biopharmaceutical company engaged in the discovery of therapies for central nervous system disorders. Christopher Kroeger, who co-founded the company in 2018, has served as its chief executive officer, president, and member of the board of directors since then.

Clinical Programs

Currently, MapLight is conducting a phase-II trial evaluating its lead product, ML-007C-MA, for the treatment of acute schizophrenia, and expects topline results in the second half of 2026. In addition, it is doing an advanced-stage trial evaluating ML-007C-MA for the treatment of ADP, with topline results expected in the second half of 2027.



Source link

Tags: debutIPOMapLightMlnNasdaqNewstargetsTherapeuticsvaluation
ShareTweetShare
Previous Post

Foreclosure Auctions Rise 19%, Giving Investors a Chance to Snag Deals

Next Post

Foreign Investors Flock to the U.S. Housing Market, Buying $56B Worth of Real Estate

Related Posts

This Key to a Happy Life Might Also Lower Your Dementia Risk

This Key to a Happy Life Might Also Lower Your Dementia Risk

by FeeOnlyNews.com
October 8, 2025
0

Shakirov Albert / Shutterstock.comHaving a sense of purpose is one key to a happy life. It also might protect you...

Foreclosure Auctions Rise 19%, Giving Investors a Chance to Snag Deals

Foreclosure Auctions Rise 19%, Giving Investors a Chance to Snag Deals

by FeeOnlyNews.com
October 8, 2025
0

In This Article Foreclosure auctions represent one of the most visible—and competitive—stages of the foreclosure process. By the time a...

Divided FOMC saw another two rate cuts by the end of 2025

Divided FOMC saw another two rate cuts by the end of 2025

by FeeOnlyNews.com
October 8, 2025
0

Federal Reserve officials in September were strongly inclined to lower interest rates, with the only dispute seeming to be over...

Could OpenAI’s Deal with AMD Break Nvidia’s Grip on AI?

Could OpenAI’s Deal with AMD Break Nvidia’s Grip on AI?

by FeeOnlyNews.com
October 8, 2025
0

I was wrong. That’s not something I say often. At least not in print. (My wife might argue the point,...

How to Make the Most Money Possible from Your Rental Property

How to Make the Most Money Possible from Your Rental Property

by FeeOnlyNews.com
October 8, 2025
0

This is how to make the most money possible from your rental properties without buying another unit. We got into...

Why Retirement in Portugal’s Algarve Is a Breeze for Americans

Why Retirement in Portugal’s Algarve Is a Breeze for Americans

by FeeOnlyNews.com
October 8, 2025
0

Charlesy / Shutterstock.comPortugal’s Algarve is a wonderful bit of European geography at the southwestern corner of the Continent, at the...

Next Post
Foreign Investors Flock to the U.S. Housing Market, Buying B Worth of Real Estate

Foreign Investors Flock to the U.S. Housing Market, Buying $56B Worth of Real Estate

Market Talk – October 8, 2025

Market Talk - October 8, 2025

  • Trending
  • Comments
  • Latest
Bitcoin: Breakout Above 7K Resistance Could Unlock Fresh Upside

Bitcoin: Breakout Above $117K Resistance Could Unlock Fresh Upside

September 19, 2025
Vanguard reaches .5M SEC settlement

Vanguard reaches $19.5M SEC settlement

August 29, 2025
Government shutdown could drain financial advisor optimism

Government shutdown could drain financial advisor optimism

October 7, 2025
Russia appeals global aviation agency’s decision blaming it for downing MH17 over Ukraine in 2014

Russia appeals global aviation agency’s decision blaming it for downing MH17 over Ukraine in 2014

September 19, 2025
B2C Marketers, Prepare Now For Agentic AI

B2C Marketers, Prepare Now For Agentic AI

September 25, 2025
OpenAI, Oracle, and Softbank expand Stargate with five new AI data centers

OpenAI, Oracle, and Softbank expand Stargate with five new AI data centers

September 23, 2025
Saratoga Investment outlines 6.8M in liquidity and maintains alt=

Saratoga Investment outlines $406.8M in liquidity and maintains $0.75 dividend amid competitive market (NYSE:SAJ)

0
The Emotional Side of Debt Consolidation

The Emotional Side of Debt Consolidation

0
Foreclosure Auctions Rise 19%, Giving Investors a Chance to Snag Deals

Foreclosure Auctions Rise 19%, Giving Investors a Chance to Snag Deals

0
Ethereum’s rising staking delays sparks fear of DeFi instability risk

Ethereum’s rising staking delays sparks fear of DeFi instability risk

0
Microsoft: KI-Dominanz trifft auf charttechnischen Widerstand!

Microsoft: KI-Dominanz trifft auf charttechnischen Widerstand!

0
A whopping 72% of S&P 500 companies disclosed AI as a ‘material risk’ on their 10-Ks this year

A whopping 72% of S&P 500 companies disclosed AI as a ‘material risk’ on their 10-Ks this year

0
Ethereum’s rising staking delays sparks fear of DeFi instability risk

Ethereum’s rising staking delays sparks fear of DeFi instability risk

October 8, 2025
Are Delta Vacations Worth It? My Honest Review

Are Delta Vacations Worth It? My Honest Review

October 8, 2025
Microsoft: KI-Dominanz trifft auf charttechnischen Widerstand!

Microsoft: KI-Dominanz trifft auf charttechnischen Widerstand!

October 8, 2025
Comic books as investment vehicles

Comic books as investment vehicles

October 8, 2025
Saratoga Investment outlines 6.8M in liquidity and maintains alt=

Saratoga Investment outlines $406.8M in liquidity and maintains $0.75 dividend amid competitive market (NYSE:SAJ)

October 8, 2025
Angel and 2521 Entertainment acquire DAVID franchise from Slingshot USA (NYSE:ANGX)

Angel and 2521 Entertainment acquire DAVID franchise from Slingshot USA (NYSE:ANGX)

October 8, 2025
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Ethereum’s rising staking delays sparks fear of DeFi instability risk
  • Are Delta Vacations Worth It? My Honest Review
  • Microsoft: KI-Dominanz trifft auf charttechnischen Widerstand!
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.